Acute Psychosis: Differential Diagnosis, Evaluation, and Management

References (46)

1. Arciniegas DB. Psychosis. Continuum (Minneap Minn). 2015;21(3 Behavioral Neurology and Neuropsychiatry):715–736. PMC4455840.
2. Gaebel W, Zielasek J. Focus on psychosis. Dialogues Clin Neurosci. 2015;17(1):9–18. PubMed CrossRef
3. Gelder M, Andreasen N, Lopez-ibor J, et al. Acute and transient psychotic disorders. In: New Oxford Textbook of Psychiatry. 2012;10:1–16. doi:10.1093/med/9780199696758.001.0001.
4. Bell V, Raihani N, Wilkinson S. Derationalizing Delusions. Clin Psychol Sci. 2021;9(1):24–37. PubMed CrossRef
5. Lieberman JA, First MB. Psychotic Disorders. N Engl J Med. 2018;379(3):270–280. PubMed CrossRef
6. Castagnini A, Galeazzi GM. Acute and transient psychoses: clinical and nosological issues. Br J Psychiatr Adv. 2016;22(5):292–300. CrossRef
7. Freudenreich O, Holt DJ, Goff DC. Psychotic patients. In: Stern TA, Freudenreich O, Smith FA, et al, eds. Massachusetts General Hospital Handbook of General Hospital Psychiatry. 7th ed. Edinburgh: Elsevier; 2017.
8. Griswold KS, Del Regno PA, Berger RC. Recognition and differential diagnosis of psychosis in primary care. Am Fam Physician. 2015;91(12):856–863. PubMed
9. Bojdani E, Zhang T, Shetty S, et al. Hypercalcemia and psychosis: case report, review of the literature, and management considerations. Prim Care Companion CNS Disord. 2018;20(6):18nr02356. PubMed CrossRef
10. Keshavan MS, Kaneko Y. Secondary psychoses: an update. World Psychiatry. 2013;12(1):4–15. PubMed CrossRef
11. Wilson JE, Mart MF, Cunningham C, et al. Delirium. Nat Rev Dis Primers. 2020;6(1):90. PubMed CrossRef
12. Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009;5(4):210–220. PubMed CrossRef
13. Fiorentini A, Cantù F, Crisanti C, et al. Substance-induced psychoses: an updated literature review. Front Psychiatry. 2021;12:694863. PubMed CrossRef
14. Marder S. Psychosis in adults: epidemiology, clinical manifestations, and diagnostic evaluation. UpToDate website. 2021. https://www.uptodate.com/contents/psychosis-in-adults-epidemiology-clinical-manifestations-and-diagnostic-evaluation
15. Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom. 2020;89(5):283–306. PubMed CrossRef
16. Freudenreich O. Secondary schizophrenia. In: Psychotic Disorders: a Practical Guide. 2nd ed. Switzerland: Humana; 2020.
17. Freudenreich O, Brown HE, Holt DJ. Psychosis and schizophrenia. In: Stern TA, Fava M, Wilens TE, et al, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed. Philadelphia, PA: Elsevier; 2016.
18. Sommer IE, de Kort GA, Meijering AL, et al. How frequent are radiological abnormalities in patients with psychosis? A review of 1379 MRI scans. Schizophr Bull. 2013;39(4):815–819. PubMed CrossRef
19. Calabrese J, Khalili YA. Psychosis. In: StatPearls. 2022. https://pubmed.ncbi.nlm.nih.gov/31536188/
20. Byrne P. Managing the acute psychotic episode. BMJ. 2007;334(7595):686–692. PubMed CrossRef
21. Stilo SA, Murray RM. Non-genetic factors in schizophrenia. Curr Psychiatry Rep. 2019;21(10):100. PubMed CrossRef
22. Stephen A, Lui F. Brief psychotic disorder; In: StatPearls. 2021. https://pubmed.ncbi.nlm.nih.gov/30969734/
23. Varchmin L, Montag C, Treusch Y, et al. Traumatic events, social adversity and discrimination as risk factors for psychosis—an umbrella review. Front Psychiatry. 2021;12:665957. PubMed CrossRef
24. Weisman O, Guri Y, Gur RE, et al; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Subthreshold psychosis in 22q11.2 deletion syndrome: multisite naturalistic study. Schizophr Bull. 2017;43(5):1079–1089. PubMed CrossRef
25. Heckers S. Who is at risk for a psychotic disorder? Schizophr Bull. 2009;35(5):847–850. PubMed CrossRef
26. Bromley S, Choi M, Faruqui S. First Episode of Psychosis an Information Guide. Revised Edition. Center for Addiction and Mental Health; 2015.
27. Perälä J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007;64(1):19–28. PubMed CrossRef
28. National Institute of Mental Health. Schizophrenia. NIMH website. https://www.nimh.nih.gov/health/statistics/schizophrenia
29. Cerimele JM, Chwastiak LA, Dodson S, et al. The prevalence of bipolar disorder in general primary care samples: a systematic review. Gen Hosp Psychiatry. 2014;36(1):19–25. PubMed CrossRef
30. Joseph SM, Siddiqui W. Delusional disorder. In: StatPearls. 2021. https://pubmed.ncbi.nlm.nih.gov/30969677/
31. Topiwala A, Hothi G, Ebmeier KP. Identifying patients at risk of perinatal mood disorders. Practitioner. 2012;256(1751):15–18, 2. PubMed
32. Smith MJ, Thirthalli J, Abdallah AB, et al. Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry. 2009;50(3):245–250. PubMed CrossRef
33. Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939–951. PubMed CrossRef
34. Zhang JP, Gallego JA, Robinson DG, et al. Efficacy and safety of individual second-generation vs first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205–1218. PubMed CrossRef
35. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–962. PubMed CrossRef
36. Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry. 2011;68(6):609–616. PubMed CrossRef
37. Hasan A, Falkai P, Wobrock T, et al; World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13(5):318–378. PubMed CrossRef
38. Paudel S, Dahal R, Mathias J, et al. Evaluation of risk factors for antipsychotic polypharmacy in inpatient psychiatry units of a community hospital: a retrospective analysis. Community Ment Health J. 2019;55(5):750–754. PubMed CrossRef
39. Grover S, Sahoo S, Rabha A, et al. ECT in schizophrenia: a review of the evidence. Acta Neuropsychiatr. 2019;31(3):115–127. PubMed CrossRef
40. Paudel S, Sharma N, Joshi A, et al. Development of a shared decision making model in a community mental health center. Community Ment Health J. 2018;54(1):1–6. PubMed CrossRef
41. Zimbroff DL. Management of acute psychosis: from emergency to stabilization. CNS Spectr. 2003;8(suppl 2):10–15. PubMed CrossRef
42. Wong AH, Ray JM, Rosenberg A, et al. Experiences of individuals who were physically restrained in the emergency department. JAMA Netw Open. 2020;3(1):e1919381. PubMed CrossRef
43. Wright A, Browne J, Mueser KT, et al. Evidence-based psychosocial treatment for individuals with early psychosis. Child Adolesc Psychiatr Clin N Am. 2020;29(1):211–223. PubMed CrossRef
44. Morrison AP, Pyle M, Maughan D, et al; MAPS group. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. Lancet Psychiatry. 2020;7(9):788–800. PubMed CrossRef
45. Dixon LB, Dickerson F, Bellack AS, et al; Schizophrenia Patient Outcomes Research Team (PORT). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36(1):48–70. PubMed CrossRef
46. Addington D, Abidi S, Garcia-Ortega I, et al. Canadian guidelines for the assessment and diagnosis of patients with schizophrenia spectrum and other psychotic disorders. Can J Psychiatry. 2017;62(9):594–603. PubMed CrossRef